ADA 2024
View a showcase of novel data and management tools from the American Diabetes Association’s 84th Scientific Sessions, taking place June 21-24 in Orlando, FL.
Hypercortisolism may play a key role in making type 2 diabetes difficult to manage.
A study highlights insurance barriers to continuous glucose monitoring among children with type 1 diabetes.
According to findings from the INHALE-3 study, inhaled insulin is a promising treatment for patients with T1D.
The use of tirzepatide in patients with obstructive sleep apnea and obesity improves both OSA severity and metabolic issues.
Fenofibrate significantly reduces the progression of diabetic retinopathy.
Exposure to BPA, an industrial chemical used to make polycarbonate plastic, may increase risk of developing type 2 diabetes.
Advertisement
Advertisement
